Literature DB >> 23917325

The nature and discriminatory value of urinary neutrophil gelatinase-associated lipocalin in critically ill patients at risk of acute kidney injury.

Neil J Glassford1, Antoine G Schneider, Shengyuan Xu, Glenn M Eastwood, Helen Young, Leah Peck, Per Venge, Rinaldo Bellomo.   

Abstract

BACKGROUND: Different molecular forms of urinary neutrophil gelatinase-associated lipocalin (NGAL) have recently been discovered. We aimed to explore the nature, source and discriminatory value of urinary NGAL in intensive care unit (ICU) patients.
METHODS: We simultaneously measured plasma NGAL (pNGAL), urinary NGAL (uNGAL), and estimated monomeric and homodimeric uNGAL contribution using Western blotting-validated enzyme-linked immunosorbent assays [uNGAL(E1) and uNGAL(E2)] and their calculated ratio in 102 patients with the systemic inflammatory response syndrome and oliguria, and/or a creatinine rise of >25 μmol/L.
MEASUREMENTS AND MAIN RESULTS: Bland-Altman analysis demonstrated that, despite correlating well (r = 0.988), uNGAL and uNGAL(E1) were clinically distinct, lacking both accuracy and precision (bias: 266.23; 95% CI 82.03-450.44 ng/mg creatinine; limits of agreement: -1,573.86 to 2,106.32 ng/mg creatinine). At best, urinary forms of NGAL are fair (area under the receiver operating characteristic [AUROC] ≤0.799) predictors of renal or patient outcome; most perform significantly worse. The 44 patients with a primarily monomeric source of uNGAL had higher pNGAL (118.5 ng/ml vs. 72.5 ng/ml; p < 0.001), remaining significant following Bonferroni correction.
CONCLUSIONS: uNGAL is not a useful predictor of outcome in this ICU population. uNGAL patterns may predict distinct clinical phenotypes. The nature and source of uNGAL are complex and challenge the utility of NGAL as a uniform biomarker.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23917325     DOI: 10.1007/s00134-013-3040-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  55 in total

1.  Oxidative stress induced lipocalin 2 gene expression: addressing its expression under the harmful conditions.

Authors:  Mehryar Habibi Roudkenar; Yoshikazu Kuwahara; Taisuke Baba; Amaneh Mohammadi Roushandeh; Shigeko Ebishima; Shinya Abe; Yasuhito Ohkubo; Manabu Fukumoto
Journal:  J Radiat Res       Date:  2007-01-16       Impact factor: 2.724

2.  Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.

Authors:  Jaya Mishra; Catherine Dent; Ridwan Tarabishi; Mark M Mitsnefes; Qing Ma; Caitlin Kelly; Stacey M Ruff; Kamyar Zahedi; Mingyuan Shao; Judy Bean; Kiyoshi Mori; Jonathan Barasch; Prasad Devarajan
Journal:  Lancet       Date:  2005 Apr 2-8       Impact factor: 79.321

3.  Early changes in organ function predict eventual survival in severe sepsis.

Authors:  Mitchell M Levy; William L Macias; Jean-Louis Vincent; James A Russell; Eliezer Silva; Benjamin Trzaskoma; Mark D Williams
Journal:  Crit Care Med       Date:  2005-10       Impact factor: 7.598

4.  Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients.

Authors:  Hilde R H de Geus; Jan Bakker; Emmanuel M E H Lesaffre; Jos L M L le Noble
Journal:  Am J Respir Crit Care Med       Date:  2010-10-08       Impact factor: 21.405

5.  Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans.

Authors:  J B Cowland; N Borregaard
Journal:  Genomics       Date:  1997-10-01       Impact factor: 5.736

6.  The development of an assay for human neutrophil lipocalin (HNL)--to be used as a specific marker of neutrophil activity in vivo and vitro.

Authors:  S Y Xu; C G Petersson; M Carlson; P Venge
Journal:  J Immunol Methods       Date:  1994-05-16       Impact factor: 2.303

7.  Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study.

Authors:  Andrea Lassnigg; Daniel Schmidlin; Mohamed Mouhieddine; Lucas M Bachmann; Wilfred Druml; Peter Bauer; Michael Hiesmayr
Journal:  J Am Soc Nephrol       Date:  2004-06       Impact factor: 10.121

8.  Assays of urine levels of HNL/NGAL in patients undergoing cardiac surgery and the impact of antibody configuration on their clinical performances.

Authors:  Linjun Cai; Jan Borowiec; Shengyuan Xu; Wenyu Han; Per Venge
Journal:  Clin Chim Acta       Date:  2009-02-07       Impact factor: 3.786

Review 9.  Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature.

Authors:  Jill Vanmassenhove; Raymond Vanholder; Evi Nagler; Wim Van Biesen
Journal:  Nephrol Dial Transplant       Date:  2012-10-31       Impact factor: 5.992

10.  Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery.

Authors:  Gebhard Wagener; Gina Gubitosa; Shuang Wang; Niels Borregaard; Mihwa Kim; H Thomas Lee
Journal:  Am J Kidney Dis       Date:  2008-07-23       Impact factor: 8.860

View more
  28 in total

1.  NGAL and AKI: the end of a myth?

Authors:  Matthieu Legrand; Michael Darmon; Michael Joannidis
Journal:  Intensive Care Med       Date:  2013-08-16       Impact factor: 17.440

2.  Biomarkers for AKI improve clinical practice: no.

Authors:  Marlies Ostermann; Michael Joannidis
Journal:  Intensive Care Med       Date:  2014-11-12       Impact factor: 17.440

3.  Biomarkers for AKI improve clinical practice: yes.

Authors:  Matthieu Legrand; Michael Darmon
Journal:  Intensive Care Med       Date:  2014-11-12       Impact factor: 17.440

4.  Measurement of AKI biomarkers in the ICU: still striving for appropriate clinical indications.

Authors:  John R Prowle
Journal:  Intensive Care Med       Date:  2015-01-22       Impact factor: 17.440

5.  Our paper 20 years later: from acute renal failure to acute kidney injury--the metamorphosis of a syndrome.

Authors:  Wilfred Druml; Kurt Lenz; Anton N Laggner
Journal:  Intensive Care Med       Date:  2015-08-22       Impact factor: 17.440

6.  Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Kathleen D Liu; Wei Yang; Alan S Go; Amanda H Anderson; Harold I Feldman; Michael J Fischer; Jiang He; Radhakrishna R Kallem; John W Kusek; Stephen R Master; Edgar R Miller; Sylvia E Rosas; Susan Steigerwalt; Kaixiang Tao; Matthew R Weir; Chi-Yuan Hsu
Journal:  Am J Kidney Dis       Date:  2014-10-11       Impact factor: 8.860

7.  Combination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass.

Authors:  John Richard Prowle; Paolo Calzavacca; Elisa Licari; E Valentina Ligabo; Jorge E Echeverri; Sean M Bagshaw; Anja Haase-Fielitz; Michael Haase; Vaughn Ostland; Eisei Noiri; Mark Westerman; Prasad Devarajan; Rinaldo Bellomo
Journal:  Ren Fail       Date:  2015-01-14       Impact factor: 2.606

8.  Whole blood neutrophil gelatinase-associated lipocalin predicts acute kidney injury in burn patients.

Authors:  Soman Sen; Zack R Godwin; Tina Palmieri; David Greenhalgh; Amanda N Steele; Nam K Tran
Journal:  J Surg Res       Date:  2015-03-20       Impact factor: 2.192

Review 9.  Implication and role of neutrophil gelatinase-associated lipocalin in cancer: lipocalin-2 as a potential novel emerging comprehensive therapeutic target for a variety of cancer types.

Authors:  Sina Rahimi; Amaneh Mohammadi Roushandeh; Ebrahim Ahmadzadeh; Ali Jahanian-Najafabadi; Mehryar Habibi Roudkenar
Journal:  Mol Biol Rep       Date:  2020-01-22       Impact factor: 2.316

10.  Urinary neutrophil gelatinase-associated lipocalin as a biomarker to monitor renal function in patients with obstructive ureteral calculi.

Authors:  Subo Qian; Yunteng Huang; Ning Wang; Yu Ding; Jun Qi; Yongjiang Yu
Journal:  World J Urol       Date:  2018-09-24       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.